{
    "2020-09-03": [
        [
            {
                "time": "",
                "original_text": "流感概念股盘中拉升走高 葵花药业涨停",
                "features": {
                    "keywords": [
                        "流感",
                        "概念",
                        "股",
                        "拉升",
                        "走高",
                        "葵花药业",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "138股获券商买入评级，会畅通讯目标涨幅达93.60%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入",
                        "评级",
                        "会畅通讯",
                        "目标涨幅",
                        "93.60%"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "通信",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康希诺生物新冠疫苗开始国际三期临床试验 于俄罗斯批准临床入组",
                "features": {
                    "keywords": [
                        "康希诺生物",
                        "新冠",
                        "疫苗",
                        "国际",
                        "三期",
                        "临床试验",
                        "俄罗斯",
                        "批准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}